SCP-868
Euclid-nuntii
~
medium confidence
SCP-868
Expected annual
$18.1M
One-time setup
$1.0B
Annual recurring
$16.4M
Personnel
25
One-time setup is dominated by research/GMP setup and large contingency reserves; recurring costs are driven by staff wages, ongoing R&D/production, surveillance/testing, and contingency/cover budgets.
One-Time Capital Costs
Total: $1.0B
Annual Recurring Costs
Total: $16.4M/yr
Cost Scenarios
📊
Baseline
(baseline)
$16.4M/yr
Normal year with no major incidents: ongoing containment, testing, R&D, and preparedness activities only.
no_breach
routine_surveillance
scheduled_R&D_and_production
🚨
Minor Incident
$17.4M/yr
Localized exposure requiring targeted follow-up amnestic distribution and expanded testing in a small town.
localized_exposure
follow-up_amnestics
small_sweep_testing
🚨
Major Breach
$36.4M/yr
City-scale outbreak requiring large-scale testing, extended quarantine, mass amnestic operations, and significant cover-up/legal actions.
urban_outbreak
mass_testing
large_quarantine_setup
🚨
Catastrophic Breach
$1.0B/yr
Wide uncontrolled spread with many Stage-Two hosts and near-collapse of secrecy requiring global-scale response and massive cleanup/containment.
widespread_stage_two
secrecy_collapse
global_response
Personnel
25 total
| Role | Count | Notes |
|---|---|---|
| Security Officer / MTF Agent | 4 | 24/7 armed guard coverage; staffing to cover shifts and leave. Costed in staff_wages. |
| Research Scientist | 4 | Memetics specialists and R&D scientists involved in AMN-868 and countermeasure development. Costed in staff_wages and R&D budgets. |
| Medical Officer | 2 | Doctors and nurses for treatment, AMN-868 administration, and on-call emergency interventions. |
| Crisis Response Team Member | 12 | Rapid-deployment containment team (10–20 person team); standby pay and equipment included in staff_wages. |
| Driver / Transport Technician | 3 | Secure vehicle crews for transfers and mobile testing units; wages included in logistics and staff_wages. |
Confidence Notes
Analyst notes provide detailed line items and ranges enabling mid-range estimates, but large uncertainties exist around outbreak probability, AMN-868 effectiveness, and worst-case systemic costs, so confidence is medium.